Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pediatric Nephrology

Life After Transplant: Hope and the Long-Term Future

At a Glance

The long-term outlook for children with Congenital Nephrotic Syndrome (CNF) after a kidney transplant is excellent. The disease does not return in the new kidney, allowing children to catch up in physical growth, attend regular school, and live full, active lives.

Back to Understanding Your Baby’s CNF Diagnosis

After the years of infusions, surgeries, and dialysis, the goal of a kidney transplant is to give your child a “normal” life. For parents of children with Congenital Nephrotic Syndrome, Finnish Type (CNF), the long-term outlook is bright. While the journey to get there is difficult, the data shows that children who reach transplantation go on to live full, active lives [1][2].

Survival and Graft Health

One of the most encouraging facts for parents is that long-term survival for children with CNF is excellent [2].

  • Graft Survival: The “graft” (the donated kidney) has a survival rate that is comparable to children who receive transplants for other common pediatric kidney conditions [1][2].
  • A “Non-Recurrent” Disease: Because CNF is a genetic condition—meaning the problem was with the original kidneys’ “blueprint”—the disease itself does not come back in the new kidney. The new kidney comes with its own healthy “blueprint” [3][4].

The Mystery of Anti-Nephrin Antibodies

While the disease doesn’t “return” in the traditional sense, some children with CNF experience a unique challenge after transplant. Because your child’s body was born without the nephrin protein, their immune system may see the nephrin in the new kidney as a “foreign invader” and create anti-nephrin antibodies to attack it [5][6].

  • Signs: This may cause protein to appear in the urine (proteinuria) shortly after the transplant [1].
  • Management: If this happens, it is not a failure of the transplant. Doctors can treat this with medications (like rituximab) or a process called plasmapheresis to “clean” the antibodies out of the blood [7]. Most children who develop these antibodies can still keep their new kidney for a long time [1].

Growth and Development: Catching Up

Years of protein loss and intensive medical care can temporarily slow a child’s physical growth. However, the post-transplant period is often a time of “catch-up” [1].

  • Physical Growth: Studies show that children with CNF see significant improvements in their height standard deviation scores (SDS)—essentially, they begin to grow at a faster rate to catch up with their peers [1].
  • Physical Performance: Some children may have slightly reduced physical performance compared to other kids, which is likely due to the many years spent in the hospital or on dialysis rather than the transplant itself [8]. Physical therapy and active play are highly encouraged to build strength [8].

Life as a “Normal” Kid

The most important long-term outcome is the quality of life. Survivors of CNF transplant:

  • Attend School: Most children attend regular school and participate in age-appropriate social activities [1].
  • Play and Socialize: While they will need to take daily medications to prevent rejection and be careful about infections, they can play, travel, and grow like any other child [8].
  • Long-Term Independence: Many children with CNF grow into healthy adults who hold jobs, start families, and manage their own health care.

Your child’s journey began in the NICU with a life-threatening diagnosis, but the transplant is the gateway to a future where their identity is defined by who they are, not just by their kidney disease [1][2].

Common questions in this guide

Does Congenital Nephrotic Syndrome come back after a kidney transplant?
No, the disease itself does not return. Because CNF is caused by a genetic defect in your child's original kidneys, the new donor kidney comes with its own healthy genetic blueprint and will not develop CNF.
What are anti-nephrin antibodies after a CNF transplant?
Since a child with CNF was born without the nephrin protein, their immune system might view the nephrin in the new kidney as a foreign invader and attack it. This can cause protein in the urine but can be effectively managed with medications or blood-filtering treatments.
Will my child catch up in growth after a kidney transplant?
Yes, the post-transplant period is often a time of significant catch-up growth. Studies show that children with CNF begin to grow at a faster rate to reach normal heights for their age once they have a functioning kidney.
What is the long-term outlook for a child with CNF after transplant?
The long-term outlook is very positive. Most children go on to attend regular school, participate in social activities, and eventually grow into healthy adults who manage their own lives and careers.
Will my child need physical therapy after their kidney transplant?
Many children benefit from physical therapy and active play after their transplant. Because of the time spent in hospitals or on dialysis, they may have slightly reduced physical performance that improves with guided strength-building exercises.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does our child's long-term graft survival chance compare to children who received transplants for other reasons?
  2. 2.If protein appears in the urine after transplant, how will you determine if it's due to anti-nephrin antibodies?
  3. 3.What medications or treatments (like rituximab or plasmapheresis) would be used if anti-nephrin antibodies develop?
  4. 4.Are there specific physical therapy or exercise programs that can help with the 'reduced physical performance' sometimes seen after transplant?
  5. 5.When can we expect our child to start catching up in height once the transplant is complete?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

    Hamasaki Y, Muramatsu M, Hamada R, et al.

    Clinical and experimental nephrology 2018; (22(3)):719-726 doi:10.1007/s10157-017-1508-4.

    PMID: 29185126
  2. 2

    Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.

    Hölttä T, Bonthuis M, Van Stralen KJ, et al.

    Pediatric nephrology (Berlin, Germany) 2016; (31(12)):2317-2325 doi:10.1007/s00467-016-3517-z.

    PMID: 27761660
  3. 3

    Usefulness of Early Genetic Diagnosis for Twins With a Family History of Congenital Nephrotic Syndrome.

    Toya Y, Ishikawa K, Yoshida T, et al.

    Cureus 2023; (15(3)):e36667 doi:10.7759/cureus.36667.

    PMID: 37101999
  4. 4

    Genetic Variations and Clinical Features of NPHS1-Related Nephrotic Syndrome in Chinese Children: A Multicenter, Retrospective Study.

    Rong L, Chen L, Rao J, et al.

    Frontiers in medicine 2021; (8()):771227 doi:10.3389/fmed.2021.771227.

    PMID: 34859019
  5. 5

    Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes.

    Tanigawa S, Islam M, Sharmin S, et al.

    Stem cell reports 2018; (11(3)):727-740 doi:10.1016/j.stemcr.2018.08.003.

    PMID: 30174315
  6. 6

    Glomeruli from patients with nephrin mutations show increased number of ciliated and poorly differentiated podocytes.

    Vukojevic K, Raguz F, Saraga M, et al.

    Acta histochemica 2018; (120(8)):748-756 doi:10.1016/j.acthis.2018.08.015.

    PMID: 30193978
  7. 7

    Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.

    Grenda R, Jarmużek W, Rubik J, et al.

    European journal of pediatrics 2016; (175(9)):1133-1137 doi:10.1007/s00431-016-2747-1.

    PMID: 27364906
  8. 8

    Physical performance capacity after pediatric kidney transplant and clinical parameters associated with physical performance capacity.

    Mäenpää H, Tainio J, Arokoski J, Jahnukainen T

    Pediatric nephrology (Berlin, Germany) 2023; (38(5)):1633-1642 doi:10.1007/s00467-022-05758-0.

    PMID: 36315277

This page provides educational information about post-transplant life for children with CNF. It does not replace professional medical advice from your child's pediatric nephrologist or transplant team.

Get notified when new evidence is published on Congenital nephrotic syndrome, Finnish type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.